MNPs/MONPs | Bacteria used | Metal precursor used | Morphology | Biomedical applications | Findings | References |
---|---|---|---|---|---|---|
CuO | Marine endophytic Actinomycetes CKV1 | Copper (II) sulfate pentahydrate | Spherical shape 10–30 nm | Antibacterial, anticancer, antibiofilm activity | At 750 µg/mL, CuO NPs showed remarkable antibacterial activity against E. Coli and P. mirabilis, exhibiting 24 mm and 28 mm zones. At 500 µg/mL, 54% inhibition was recorded against A549 cells | [127] |
Streptomyces sp. MHM38 | Copper (II) sulfate | Spherical 1.72–13.49 nm | Antimicrobial | CuO nanoparticles showed antibacterial efficacy against Enterococcus faecalis, Salmonella typhimurium, E. coli, P. aeruginosa, and Candida albicans | [128] | |
Marinomonas Rhodococcus Pseudomonas Brevundimonas Bacillus | Copper (II) sulfate pentahydrate | Spherical/ovoidal shapes 40 nm | Antibacterial, antifungal | The MIC of CuO NPs ranged from 3.12 to 25 µg/mL for Gram-negative bacteria, 12.5 to 25 µg/mL for Gram-positive bacteria, and 12.5 to 25 µg/mL for fungi | [129] | |
Actinomycetes | Copper (II) sulfate pentahydrate | Crystalline 198 nm | Antibacterial | B. cereus showed high susceptibility (25.3 mm) to CuO NPs. The CuO NPs inhibited bacterial pathogens B. cereus, P. mirabilis, and A. caviae at 5 µg/mL | [130] | |
ZnO | Cyanobacterium Nostoc sp. EA03 | Zinc acetate dihydrate | Star-like shape 50–80 nm | Antibacterial, anticancer activity | MIC and MBC values for E. coli, P. aeruginosa, and S. aureus were found to be 2000, 2000, and 64 µg/mL, and 2500, 2500, and 128 µg/mL, respectively. ZnO NPs were less cytotoxic to MRC-5 lung fibroblast cells than to A549 cells treated with cancer | [131] |
Paraclostridium benzoelyticum strain 5610 | Zinc nitrate | Spherical/rectangular shape 50 nm | Antibacterial, anti-inflammatory, antidiabetic | Inhibitory zone of Helicobacter suis measured 19.53 ± 0.62 mm at 5 mg/mL. After 21 days. In arthritis model the edema was inhibited by NPs by 87.62 ± 0.12%. ZnO NPs sharply reduced glucose level in STZ-induced diabetic mice | [132] | |
B. subtilis ZBP4 | Zinc sulfate heptahydrate | Pseudo-spherical 14–45 nm | Antibacterial | For B. cereus, S. aureus, E. coli O157:H7, E. coli Type 1, and P. aeruginosa the MIC was 1 mg/mL. It was 2 mg/mL for L. monocytogenes and S. typhimurium | [133] | |
Saccharomyces cerevisiae | Zinc acetate dihydrate | Spherical 20–30 nm | Antioxidant, antibacterial, anticancer, photocatalytic activity | ZnO NPs showed concentration-dependent increases in anti-cancer activity. At 100 µg/mL, ZnO NPs inhibited 93% cells | [134] | |
TiO2 | B. subtilis | Titanium dioxide | Spherical 70.17Â nm | Treatment of dental caries | Dental caries responded best to treatment with 5% TiO2, which had no discernible cytotoxic effects | [135] |
Rummelii pycnus Acinetobacter baumanii Acinetobacter seohaensis Bacillus cereus | Titanium Oxychloride | Spherical/irregular 8Â nm | Antibacterial | Maximum zone of inhibition was found at 50Â mL of TiO2 NPs | [136] | |
Streptomyces sp. HC1 | Titanium oxyhydroxide | Spherical 30–70 nm | Antimicrobial, antibiofilm | The highest level of antibiofilm activity was shown by 500 μL TiO2 NPs produced by Streptomyces sp. HC1. Maximum zone of inhibition was recorded against S. aureus and E. coli | [137] | |
Ag | Streptomyces rochei MS-37 | Silver nitrate | Spherical 23.2 nm | Antibacterial, anti-inflammatory, antioxidant | Ag NPs had IC50 value of 34.03 µg/mL in CAL27 and 81.16 µg/mL in human peripheral blood mononuclear cells, indicating CAL27 was more susceptible to the NPs cytotoxicity. Ag NPs had MIC ranging from 8 to 128 µg/mL | [138] |
Streptomyces parvus | Silver nitrate | 9.7–17.25 nm | Antimicrobial, antioxidant | K. pneumoniae (28.33 mm) and E. coli (21.66 mm) were susceptible to antibacterial activity. When compared to E. faecalis (125 μg/mL), S. aureus (250 μg/mL), P. aeruginosa (125 μg/mL), K. pneumoniae (500 μg/mL), and E. coli (250 μg/mL), the MIC of Ag NPs was significant | [139] | |
Nocardiopsis dassonvillei | Silver nitrate | Spherical 29.28 ± 2.2 and 32.13 ± 3.4 nm | Antimicrobial, antioxidant, anticancer | Ag NPs showed notable scavenging activity with IC50 values of 4.08 and 8.9 µg/mL against OH and DPPH radicals, respectively. Ag NPs with CaCo2 cells demonstrated concentration dependent reduction in cell viability. Lactate dehydrogenase leakage increased as cell viability declined | [140] | |
Bacillus amyloliquefaciens MSR5 | Silver nitrate | Spherical/cubical/and regular 29.2Â nm | Anticancer, catalytic activity | Using NaBH4, Ag NPs demonstrated potent chemocatalytic action, completely degrading 4-NP to 4-aminophenol (4-AP) in 15Â min. Ag NPs activated A549cells | [141] | |
Bacillus brevis (NCIM 2533) | Silver nitrate | Spherical 41 nm | Antibacterial | Ag NPs demonstrated mean zone of inhibition 14, 15, 16, and 19 mm against S. aureus at 5, 10, 15, and 20 μL | [142] | |
Au | Streptomyces sp. NH21 | Chloroauric acid | Spherical/rod 18–20 nm | Antibacterial | Ag NPs had MIC of 2.5 µg/mL against E. coli, 5 µg/mL against K. pneumoniae, P. mirabilis, and S. infantis, and 10 µg/mL against P. aeruginosa and B. subtilis. For P. aeruginosa and B. subtilis minimum bactericidal concentrations were 140 and 170 µg/mL | [143] |
Vibrio alginolyticus | Chloroauric acid | 100–150 nm | Antioxidant, anticancer | Colon cancer cell growth inhibited by Au NPs in a dose-dependent manner. 25 µg/mL resulted in maximum inhibition of cell death (> 75%), with an IC50 of 15 µg/mL | [144] | |
Paracoccus haeundaensis BC74171T | Chloroauric acid | Spherical 20.93 ± 3.46 nm | Antioxidant, anticancer | In HaCaT and HEK293 normal cells, Au NPs did not exhibit growth inhibition. Au NPs exhibited concentration dependent growth inhibition against A549 and AGS cancer cells | [145] | |
Enterococcus sp. RMAA | Gold chloride | Spherical | Anticancer | Mitochondrial membrane potential was lowered, ROS and caspase-3 expressions were increased | [146] |